Aspiriant LLC’s Vanguard FTSE All-World ex-US Small-Cap Index Fund VSS Stock Holding History

Aspiriant LLC’s Portfolio VSS Stock Details VSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.7M	Buy	94,651 +138	+0.1%	+$21.6K	0.36%	39
2026 Q2	$14.6M	Buy	94,513 +1,570	+2%	+$246K	0.36%	39
2026 Q1	$13.6M	Sell	92,943 -319	-0.3%	-$48.2K	0.39%	38
2025 Q4	$13.4M	Sell	93,262 -13,051	-12%	-$1.86M	0.38%	38
2025 Q3	$15.2M	Sell	106,313 -5,461	-5%	-$756K	0.46%	33
2025 Q2	$15M	Sell	111,774 -767	-0.7%	-$94.6K	0.48%	32
2025 Q1	$13M	Buy	112,541 +4,211	+4%	+$489K	0.45%	30
2024 Q4	$12.4M	Sell	108,330 -1,048	-1%	-$126K	0.45%	33
2024 Q3	$13.8M	Sell	109,378 -197	-0.2%	-$23.7K	0.52%	29
2024 Q2	$12.9M	Buy	109,575 +3,238	+3%	+$380K	0.52%	31
2024 Q1	$12.4M	Sell	106,337 -1,913	-2%	-$216K	0.51%	31
2023 Q4	$12.5M	Buy	108,250 +1,783	+2%	+$192K	0.56%	30
2023 Q3	$11.3M	Buy	106,467 +4,301	+4%	+$477K	0.58%	28
2023 Q2	$11.3M	Sell	102,166 -1,061	-1%	-$117K	0.57%	29
2023 Q1	$11.3M	Sell	103,227 -25,289	-20%	-$2.75M	0.59%	29
2022 Q4	$13.2M	Sell	128,516 -248,787	-66%	-$25M	0.67%	25
2022 Q3	$35M	Buy	377,303 +250,883	+198%	+$26.1M	1.71%	13
2022 Q2	$13.1M	Buy	126,420 +109,202	+634%	+$12.4M	0.63%	25
2022 Q1	$2.14M	Buy	17,218 +2,676	+18%	+$336K	0.12%	85
2021 Q4	$1.95M	Buy	14,542 +3,120	+27%	+$422K	0.1%	90
2021 Q3	$1.53M	Buy	11,422 +4,550	+66%	+$626K	0.09%	90
2021 Q2	$937K	Buy	6,872 +2,026	+42%	+$274K	0.05%	119
2021 Q1	$623K	Sell	4,846 -4,256	-47%	-$539K	0.04%	133
2020 Q4	$1.11M	Buy	+9,102	New	+$1.03M	0.08%	92
2019 Q2	–	Sell	-2,000	Closed	-$208K	–	240
2019 Q1	$208K	Buy	+2,000	New	+$203K	0.02%	218
2018 Q4	–	Sell	-2,000	Closed	-$224K	–	252
2018 Q3	$224K	Hold	2,000	–	–	0.02%	217
2018 Q2	$231K	Buy	+2,000	New	+$240K	0.02%	228

Other funds holding VSS

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Columbus Macro New Castle, Pennsylvania $1.03B AUM 10.45% 1-Year Est. Return

Discipline Wealth Solutions Greenville, South Carolina $1.15B AUM 12.89% 1-Year Est. Return

IFG Advisors St. Louis, Missouri $730M AUM 19.37% 1-Year Est. Return

25 LLC St. Louis, Missouri $367M AUM 10.52% 1-Year Est. Return

MWM

Maltin Wealth Management Ridgewood, New Jersey $308M AUM 16.5% 1-Year Est. Return

Aspiriant LLC's VSS Position: Q3 2026 in Review

Aspiriant LLC increased its Vanguard FTSE All-World ex-US Small-Cap Index Fund (VSS) stake by 0.15% in Q3 2026, buying an estimated $21.6K and bringing the position to 94,651 shares worth $14.7M. The position accounts for 0.36% of the portfolio, ranked #39.

Aspiriant LLC first reported a position in VSS in Q2 2018 and has held it in 27 quarters since. The position peaked at $35M in Q3 2022. 147 funds tracked by Wall St. Rank hold VSS as of Q3 2026.

Aspiriant LLC held 94,651 shares of Vanguard FTSE All-World ex-US Small-Cap Index Fund worth $14.7M as of Q3 2026.
Aspiriant LLC bought 138 Vanguard FTSE All-World ex-US Small-Cap Index Fund shares in Q3 2026, an estimated $21.6K.
Vanguard FTSE All-World ex-US Small-Cap Index Fund made up 0.36% of Aspiriant LLC's portfolio in Q3 2026, its #39 holding.
Aspiriant LLC first reported a position in Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q2 2018 and has held it in 27 quarters since.
Aspiriant LLC's Vanguard FTSE All-World ex-US Small-Cap Index Fund position peaked at $35M in Q3 2022.
147 funds tracked by Wall St. Rank held Vanguard FTSE All-World ex-US Small-Cap Index Fund as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.